Qiming Headlines | Qiming Venture Partners Healthcare Innovation Investment Team Launches 2026 PhD Fall/Winter Internship Program | Bilingual
In this 8- to 10-week internship program, you'll have the opportunity to work alongside some of the most innovative founders in biotech, medtech, and AI-powered healthcare — with dedicated growth opportunities designed just for you.
Swipe Left for the English Version
On October 20, the Healthcare Investment Team at Qiming Venture Partners launched our 2026 PhD Fall/Winter Internship Program. If you're passionate about investing and entrepreneurship, apply now!
Through this 8-10 week internship program, you will have the opportunity to work alongside the most innovative founders in biotech, medtech, AI healthcare, and other fields, while gaining exclusive opportunities for growth.
About Qiming Venture Partners
Qiming Venture Partners is a top-tier venture capital firm with a strong global reputation. We currently manage eleven US dollar funds and seven RMB funds, with total assets under management reaching $9.5 billion. Since our founding, we have focused on investing in outstanding companies at the early and growth stages in Technology and Healthcare.
Qiming Venture Partners has a professional investment team composed of founders, entrepreneurs, scientists, engineers, doctors, consultants, and financial experts, with extensive experience in building and operating businesses. Over the past 20 years, the rapidly growing healthcare companies we have invested in have largely become leaders in their respective fields, developing synergistically within the Qiming ecosystem and creating greater value across more innovative areas.
Inclusiveness, ambition, and humility define our culture. Here, colleagues get along well, the work atmosphere is harmonious and friendly, and teamwork is close-knit. We hope to work with emerging talent to find the most outstanding entrepreneurs, address clinical needs, and create social good.
Join the Qiming Venture Partners PhD Fall/Winter Internship Program
You will have a unique opportunity to gain:
-
Comprehensive understanding and solid training in venture capital: Grounded in rigorous market research, you will work closely with industry experts in healthcare innovation, participating in the full spectrum of VC day-to-day activities including deal sourcing, due diligence, and deal execution, comprehensively developing your fundamental skills and industry insights in early-stage healthcare investment;
-
Immersive hands-on experience: Collaborate with our professional partners and top industry mentors, deeply engaging in investment practice. You will also have opportunities to communicate directly with startup founders, identifying market opportunities and assessing deal value;
-
Build a broad network in the healthcare industry: Engage face-to-face and work closely with influential founders of Qiming Venture Partners portfolio companies and industry leaders, accumulating expertise while helping businesses grow and building your own healthcare industry network;
-
Make real impact: Your research findings will be formally presented to our investment team, receiving professional feedback and targeted guidance, and may even directly influence our investment decisions;
-
Ongoing opportunities for exceptional performers: Those who perform excellently during the internship may continue with remote part-time internship opportunities after the program concludes; those with particularly outstanding overall performance will have the chance to secure a formal full-time position.
We are looking for you
-
PhD students currently enrolled at top global universities
-
Current PhD research directions include but are not limited to: biomedicine, bioengineering, AI healthcare, healthcare embodied intelligence, etc.
-
Candidates with backgrounds in both AI and frontier technologies are preferred, such as large models, embodied AI, quantum computing, etc.
-
Keen insight and judgment into frontier technologies, along with strong intellectual curiosity
-
Strong entrepreneurial spirit
The fall/winter internship requires full-time, on-site work in Beijing or Shanghai, with flexibility for domestic travel during the internship period
Apply Now
Experience industry development together!
Please send your resume to HR@qimingvc.com before November 20, 2026. Please include your name, university, major, and current PhD year in your resume.
Qiming Venture Partners Opens Applications for 2026 Healthcare PhD Fall/Winter Internship
PhD Fall/Winter Intern – Healthcare
Shanghai / Beijing
Biotech / Medtech / AI Healthcare
On October 20, the Healthcare Investment Team at Qiming Venture Partners launched our 2026 Healthcare PhD Fall/Winter Internship Program. Start your healthcare investment journey with us!
Through this 8-10 week internship program, you will gain hands-on experience working with the most innovative founders across Biotech, Medtech, AI in Healthcare, and more, along with unique opportunities for growth.
About Qiming Venture Partners
Qiming Venture Partners was founded in 2006. Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companies in the Technology and Healthcare industries at the early and growth stages.
Our professional investment team consists of founders, entrepreneurs, scientists, engineers, doctors, consultants, and financial experts. We have extensive experiences in building and operating a business.
Since our establishment, Qiming Venture Partners has earned extensive recognition from investors worldwide and has become an ideal VC firm for entrepreneurs, due to our exceptional investment performance. Our firm and our partners consistently rank among the leaders in the global venture capital industry across various prestigious lists.
Inclusiveness, ambition and humility are at the heart of Qiming Venture Partners' culture. We enjoy a friendly, harmonious, and cooperative working environment. We hope to work with young talents to find outstanding entrepreneurs, address clinical needs, and contribute to social good.
Get a unique chance to:
- Gain comprehensive exposure to the VC world: Through solid market research, you will work closely with our healthcare experts on deal sourcing, due diligence, and deal execution to shape your early-stage investment themes in healthcare.
- Learn from practice: Train with our expert partners and top industry mentors in the fundamentals of VC investment. You will talk directly to start-up founders, to identify market opportunities and assess real-world deal dynamics.
- Build a broad network in the healthcare industry: Communicate directly with influential CEOs of Qiming Venture Partners' portfolio companies and industry Key Opinion Leaders. Help them succeed, and build your own industry network along the way.
- Make a real impact: Formally present your findings to our VC investment team for feedback and mentorship. Your input may directly influence our investment decisions.
- Unlock ongoing opportunities: Qualified interns will be offered a remote part-time internship after the internship. Outstanding candidates will have an opportunity for a full-time position after the program.
Requirements:
-
PhD candidates currently enrolled in top-tier universities in the US/UK
-
Current PhD research areas include, but are not limited to: biomedicine, bioengineering, AI in healthcare, and robotics related to healthcare, etc.
-
Candidates with a background in AI or frontier technologies (e.g., large language models, embodied AI, quantum computing) are preferred
-
Sharp instinct for cutting-edge technologies
-
Strong entrepreneurial spirit
-
Available for a full-time, on-site internship in Beijing/Shanghai, and flexible to travel
**Please submit your resume to HR@qimingvc.com before Nov. 20th 2026. Please include your name, university, major, and current PhD year in the resume.
往 期 回 顾
Qiming Venture Partners was founded in 2006. Currently, Qiming Venture Partners manages eleven US dollar funds and seven RMB funds, with total assets under management reaching $9.5 billion. Since our founding, we have focused on investing in outstanding companies at the early and growth stages in Technology and Healthcare.
To date, Qiming Venture Partners has invested in over 580 rapidly growing innovative companies, of which more than 210 have listed on the New York Stock Exchange, NASDAQ, Hong Kong Exchanges and Clearing Limited, Shanghai Stock Exchange, and Shenzhen Stock Exchange, or exited through M&A and other means. Over 80 companies have become recognized unicorns or super-unicorns.
Many companies in Qiming Venture Partners' portfolio have grown into the most influential players in their respective fields, including Xiaomi (01810.HK), Meituan (03690.HK), Bilibili (NASDAQ:BILI, 09626.HK), Zhihu (NYSE:ZH, 02390.HK), Roborock (688169.SH), Hesai Technology (NASDAQ:HSAI, 02525.HK), UBTECH (09880.HK), WeRide (NASDAQ:WRD, 0800.HK), HyperStrong (688411.SH), Insta360 (688775.SH), Unisound (09678.HK), Biren Technology (06082.HK), Zhipu (02513.HK), Gan & Lee Pharmaceuticals (603087.SH), Tigermed (300347.SZ, 03347.HK), Zai Lab (NASDAQ:ZLAB, 09688.HK), CanSino Biologics (688185.SH, 06185.HK), Schrödinger (NASDAQ:SDGR), APT Medical (688617.SH), Sanyou Medical (688085.SH), AmoyDx (300685.SZ), Sinocelltech (688520.SH), Insilico Medicine (03696.HK), Haobo Bio, Yuanxin Technology, MediLink Therapeutics, Leads Biolabs, StepFun, and others.